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Introduction
The opioid epidemic remains a public health crisis impacting the United States (U.S.).
The economic cost of the opioid crisis is estimated to be $504 billion, with over 33,000
Americans dying of an opioid-related overdose annually (1). Opioids are prescribed for pain
relief from surgery; however, they are highly addictive and have a range of side effects. The
opioid crisis is not limited to the adult population (2). Millions of children undergo ambulatory
surgery in the U.S. each year (3) and many are prescribed opioids for their postoperative pain.
Recent trends have started to raise questions about the use of opioids for pediatric patients (4-6).
Children and adolescents are vulnerable to brain changes in the habit formation and reward
centers of the brain (7), and patients prescribed opioids at a young age are at risk for later
problems with misuse and dependence (8, 9). Nevertheless, surgery and postoperative pain in
children are very common, making adequate pain control also a significant concern (10, 11).
Despite the adverse effects of opioids, they do have significant therapeutic advantages for
managing moderate to severe acute pain (12).
Recent trends dictate that many surgeries in children are now performed on an outpatient
(as opposed to inpatient) basis, making parents accountable for their child’s pain management
and recovery (11). Current outpatient guidelines for managing and preventing post-surgical pain
recommend the use of oral opioid and non-opioid analgesics to be administered "as needed" or
on a pain contingent basis (13). Unfortunately, there is a gap in interpretation of these guidelines
to manage pain at home, as many parents struggle with optimal analgesic administration (14, 15).
This is problematic, as the undertreatment of pediatric postsurgical pain can result in delayed
recovery (16), unexpected hospitalization (17), and chronic or persistent pain (18).
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One determinant of pain and its management is ethnic identification (19-21), which
represents a person's self-classification into an ethnic group. While ethnicity is used to
distinguish groups of people based on their shared culture, history, social background, and
beliefs, race differentiates people based on physical characteristics (19, 22). Furthermore, pain is
argued to be shaped by the interactive effects of biological (e.g., genetics), psychological (e.g.,
coping strategies), and social (e.g., family history and culture) factors (23, 24), which are all
highly influential in a person's cultural identification (25).
In the U.S., the Hispanic/Latinx population is the largest minority group constituting
approximately 18.1% of the total population (26). Research examining the impact of ethnicity on
the pain experience suggests that Hispanic/Latinx adults report higher levels of postsurgical pain
(27) and exhibit a greater number of physical pain symptoms (20, 28), but receive fewer opioids
(29-31) compared to Non-Hispanic Whites (NHW). Similar racial/ethnic differences in pain (32)
and its management for children have been shown in the emergency department (33-35), postanesthesia care unit (36), and in an outpatient setting (37, 38). These observed differences might
be explained by several factors such as patient communication style (39), language preference
(40), socioeconomic status (34), financial constraints to pay for care (41), and physician implicit
bias (42), and indicate that minority pediatric patients might be at risk for suffering from
postsurgical pain disproportionally compared to their NHW counterparts (32, 43).
For pediatric patients, home-based recovery and pain management is dependent on
parental pain assessment and the decision to respond by administering analgesic medication.
Specifically, research suggests that parent responses to their children's emotional and behavioral
expressions of pain are often mediated by cultural beliefs, expectations, and past experiences,
which all differ based on cultural/ethnic identity (44). Due to the growing Hispanic/Latinx
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population in the U.S., it is crucial to understand the pain management attitudes and behaviors of
Hispanic/Latinx parents in order to help improve pediatric recovery. For example, cultural
barriers might impact the analgesic usage behaviors of Hispanic/Latinx Americans. This
population is shown to cope with pain by remaining stoic by suffering through pain without
complaining, and bearing pain with courage and dignity (45). Stoicism is often learned from the
family (45), and is utilized to avoid appearing weak, and to suppress behaviors that might burden
others (41, 46). This cultural emphasis on stoicism might impact child pain expression (15, 47),
and parent responses to child pain.
Parental beliefs might also represent a pain management barrier. Previous research by our
group shows that compared to NHW parents, Hispanic/Latinx parents report greater
misconceptions regarding pain expression (e.g., the belief that children always express pain by
crying and always tell their parents when they are in pain) and analgesic administration (e.g., fear
of side-effects and addiction) (15, 48), and that Hispanic/Latinx parents often do not administer
adequate doses of analgesic medications to their children despite reports that they experienced
clinically significant postsurgical pain (14). Medication-related fears and misunderstandings are
often rooted in cultural context (49). Research suggests that Hispanic/Latinx Americans possess
concerns about taking strong pain medications and believe opioid medications to be dangerous
(46, 50). As a result, Hispanic/Latinx patients might alter prescribed doses (49) or exhibit a
preference for traditional treatment methods (e.g., herbs, ointments) that are perceived as safer
and more effective than opioid medications.
The cited studies suggest that parent pain interpretations and attitudes about analgesic
medication might represent a barrier to medication adherence. The current study aims to expand
this previous body of research (14, 15, 48) by assessing how Hispanic/Latinx and NHW parents
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alter their child’s opioid consumption in response to significant postsurgical pain. Parents of
Hispanic/Latinx children were hypothesized to report their child experienced greater pain
(Hypothesis 1) (38), but received fewer opioids (Hypothesis 2) during recovery compared to
NHW children (33, 36). Also, an interaction of ethnic identification and parent-reported pain on
opioid consumption was posited (Hypothesis 3), such that Hispanic/Latinx parents were expected
to be less likely to adjust their child’s opioid dose based on pain level compared to NHW parents
(14, 35).
Method
Patients and Procedure
The current study involves a secondary data analysis of baseline longitudinal data
collected with children and parents for an NIH funded larger randomized clinical trial centered
on examining the effectiveness of a provider tailored intervention for perioperative stress
(R01HD048935). The larger clinical trial was conducted from 2012 to 2017 and was funded by
the Eunice Kennedy Shriver National Institute of Child Health and Human Development (51).
Participants were pediatric patients between the ages of 2 and 15 and their parents. Patients
underwent outpatient T&A surgery at the Children’s Hospital of Los Angeles (CHLA),
Children’s Hospital of Orange County (CHOC), Children’s Hospital, Colorado (CHC), and
Lucile Packard Children’s Hospital at Stanford (LPC). The larger clinical trial consisted of
observational baseline and intervention phases. For the purpose of the present report, we used
data only from the observational baseline data (before any intervention) and control group data.
Patients were required to have an American Society of Anesthesiologists physical health
status of I-III and be English- and/or Spanish-speaking. Exclusion criteria included children with
chronic illness that puts them in ASA IV (extreme systemic disorders which have already
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become an eminent threat to life regardless of the type of treatment), having a developmental
delay or special need, and being born prematurely (<32 weeks gestational age).
On the day of surgery, research assistants obtained written parent consent and patient
assent after fully explaining the nature of the study procedures. While waiting in the holding
area, parents completed a paper and pencil preoperative survey in their preferred language that
included demographic measures. Parents were given standardized prescription medication
discharge information and instructions in their primary language. After returning home from the
hospital, parents completed a paper and pencil daily diary entry as part of the study, recording
their child’s level of pain and the medications taken. Pain was recorded once per day; medication
use was recorded up to seven times per day. Parents continued to record their child’s medication
use and pain level on the first 3 days and the 7th day following surgery. Protocols were approved
by an institutional review board at each of the four sites.
Within-Patient Measures
Parent-reported pain. Parent perceptions of child pain was operationalized using parent
report on the Numeric Rating Scale (NRS) with responses ranging from 0 (No Pain) to 10
(Severe Pain). This rating scale has been shown to be reliable and valid indicator of pain in
pediatric patients (52), and has been used to assess parent global ratings of their child’s pain
using a daily diary format (10).
Hydrocodone/APAP consumption. Hydrocodone/acetaminophen (APAP) liquid
consumption (mg/kg) was measured by having parents record the medication type and dose
administered to their child throughout the week after returning home from the hospital. A sum of
the amount of hydrocodone/APAP consumed in mg/kg was computed for each of the
postoperative days. Current guidelines (53) suggest administering 0.1 - 0.2 mg/kg of

7
hydrocodone APAP every 4 to 6 hours (i.e., 0.4 – 1.2 mg/kg per day). Patients who did not take
hydrocodone/APAP, but took acetaminophen only received a value of 0 for hydrocodone/APAP
consumption.
Additional acetaminophen use. Additional acetaminophen use (mg/kg; e.g., children’s
acetaminophen liquid, junior acetaminophen liquid) was computed for each day.
Hydrocodone/APAP contains both hydrocodone and acetaminophen. Thus, this measure controls
for acetaminophen use, in addition to the dose of hydrocodone taken. Parents recorded the type
and dose of acetaminophen administered. Children who took only Hydrocodone/APAP only
were given a value of 0 for additional acetaminophen.
Between-Patient Measures
The year of data collection, hospital site, and procedure type were included as control
variables. Parents reported their household income range and education level, and their child’s
age, sex, and ethnic identification. For children with one parent, education level reflects the value
of that parent only.
Data Preparation
One hospital, LPC, did not prescribe opioids to any patients, and was therefore removed
from the analysis. Participants were children who underwent T&A surgery at CHLA, CHOC, or
CHC, that took either hydrocodone/APAP liquid or acetaminophen-only, and reported at least
one pain response (N = 305). Given the low sample size of African American and Asian
participants meaningful differences could not be examined. In total, 34 participants were
removed from the sample because they did not fall into either ethnicity category.
Three participants were identified as having univariate outliers (> 3 standard deviations
from the mean) and 14 were found to be multivariate outliers using the Mahalanobis distance test
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(54). All 17 outliers were removed before conducting statistical tests (N = 254). Missing data
was also assessed (Table 1). Binary logistic regression modeling was used to compare rates of
missing data for Hispanic/Latinx and NHW patients, while controlling for hospital site. Findings
showed no significant ethnicity-based differences for income, education, hydrocodone/APAP,
acetaminophen, or pain (see Table 1). Across all variables, rates of missingness were similar
Hispanic/Latinx and NHW patients (OR = 0.60, p = 0.28). The data was also examined for
systematic patterns of missingness. No patterns emerged; thus, the data was considered to be
missing at random. In line with current recommendations (55), analyses employed maximum
likelihood procedures. Further, stochastic regression imputation was used under the conditions of
missing at random to address any potential biasing effect of missing data at Level 2 (betweenpatient) (56).
Statistical Analysis
Longitudinal multilevel modeling (MLM), using the SPSS mixed procedure (57, 58) was
performed using robust maximum likelihood estimation to assess the changes in both pain and
hydrocodone/APAP consumption 1 to 7 days post-surgery. The repeated measures of pain,
hydrocodone/APAP consumption, and additional acetaminophen use were conceptualized nested
within each patient, and changes in both pain and hydrocodone/APAP were examined at two
levels—within patient (Level 1; intra-individual) and between patient (Level 2; inter-individual)
(57, 59). A major advantage of using MLM is that missing data at Level 1 can be handled
flexibly. All available data can be included, meaning that individuals with data missing on one or
two time points can still be used in the analyses (60). All variables were standardized (Z-scored)
prior to conducting analyses (57, 61). This approach is suitable for fixed-effect models and
enables the interpretation of standardized regression coefficients.
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Separate MLM analyses were conducted to evaluate changes in both pain and
hydrocodone/APAP consumption overtime. Models were successively specified to produce
models that could be statistically compared using the −2LL and AIC (57). Model 1 estimated
baseline model to compute the intraclass correlation (ICC), an assessment of whether the
outcome variable changes between patients overtime (57, 62). Model 2a estimated a linear
growth model with time as the only predictor to examine overall and individual differences in
pain and hydrocodone/APAP use overtime. Model 2b scrutinized a quadratic growth curve
model, examining whether pain level and hydrocodone/APAP use accelerated or decelerated
overtime. In both Model 2a and 2b time was specified as a random parameter to examine
between-subject variations in the relationship between the outcome variables and time.
Model 3 incorporated all fixed-effect predictors to identify which variables explained
differences in the growth curve trajectory of pain level and hydrocodone/APAP use. When
assessing hydrocodone/APAP use as the outcome variable, a cross-level interaction of pain level
and ethnic identification was also incorporated into Model 3. Significant interaction effects were
decomposed using a test of simple slopes (63). An online calculator (64) was used to probe the
cross-level interaction, with pain level assessed at 1 standard deviation below the mean, at the
mean, and 1 standard deviation above the mean for Hispanic/Latinx and NHW patients.
An important consideration of longitudinal MLM is whether residual error varies
overtime (65). When estimating hierarchical linear models, it is appropriate to assess whether the
specification of different covariance structures impact model fit. Covariance structures typically
implemented when multiple waves of measurement are obtained include diagonal (DIAG), firstorder auto-regressive (AR1), compound symmetry (CS), heterogeneous autoregressive (ARH1),
and unstructured (UN). To assess whether residual error variances were heteroscedastic versus
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homoscedastic across measurement periods, a likelihood ratio test was used to compare random
intercepts models for pain and hydrocodone APAP consumption. The heteroscedastic error
variance model estimated the variance components at Level 1 by specifying the DIAG
covariance structure for the repeated covariance type. The UN matrix was used for the
homoscedastic model estimation (57). In both the pain and hydrocodone APAP random
intercepts models, the likelihood ratio test showed that the models with an UN matrix exhibited a
better model fit (both p = .001), suggesting heteroskedasticity of error terms overtime. To
account for this, an UN covariance matrix was used in all analyses to estimate random intercepts
(UN 1,1), random slopes (UN 2,2) and the covariance between intercept slopes (UN 2,1) (57).
Results
The final sample (Table 1) consisted of 254 pediatric patients ranging from ages 2 to 15.
In total, 146 patients were Hispanic/Latinx and 108 were NHW. Average pain scores and
hydrocodone/APAP consumption for both Hispanic/Latinx and NHW patients are depicted in
Table 2.
Table 1.
Descriptive Statistics and Rates of Missing Data
Descriptive Statistics

M (SD)

Level 1 (within-patient)

Hydrocodone/
APAP
Consumption
(mg/kg)

Missing Data
Hispanic/
NHW
Latinx
Patients
Patients
n = 146
n = 108
(n
(n
missing) missing)

Day 1

0.20 (0.18)

31.1%

58

21

Day 2

0.20 (0.20)

37.8%

66

30

Day 3

0.19 (0.19)

50.0%

87

40

Day 7

0.06 (0.12)

57.1%

82

63

Total

0.17 (0.19)

Day 1

12.36 (18.08)

31.1%

58

21

a

Acetaminophen
Consumption

Total
Patient
Sample
N = 254
(%
missing)

OR, pvalueb

OR = 0.77,
p = 0.44
OR = 0.90,
p = 0.74
OR = 0.99,
p = 0.97
OR = 0.88,
p = 0.69
OR = 0.77,
p = 0.44
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(mg/kg)

ParentReported Pain

OR = 0.90,
p = 0.74
OR = 0.99,
p = 0.97
OR = 0.88,
p = 0.69

Day 2

14.40 (18.98)

37.8%

66

30

Day 3

13.97 (18.10)

50.0%

87

40

Day 7

11.96 (12.47)

57.1%

82

63

Totala

13.21 (17.41)

Day 1

5.61 (2.51)

22.8%

44

14

Day 2

5.21 (2.67)

26.8%

50

18

Day 3

4.20 (2.66)

37.0%

66

28

Day 7

3.62 (2.65)

33.5%

51

34

Totala

4.71 (2.73)
13.4%
63.0%
14.2%
8.7%
0.8%
34.6%/
26.8%/
38.6%

---

---

---

---

---

---

---

---

90.6%

---

---

---

---

16.9%

30

13

OR = 0.72,
p = 0.42

6.7%

14

3

OR = 0.51,
p = 0.35

Level 2 (between-patient)
2012
2013
Year
2014
2015
2016
CHLA/
Hospital Site
CHOC/
CHC
Tonsillectomy
Procedure
&
Adenoidectomy
Adenoidectomy
only
Tonsillectomy
only
Less than
$10,000
$11,000 to
$20,000
$21,000 to
$30,000
$31,000 to
$50,000
Family Income
$51,000 to
$80,000
$81,000 to
$100,000
$100,000 to
$200,000
More than
$200,000
Parent
M (SD)
Education

OR = 0.68,
p = 0.33
OR = 0.79,
p = 0.52
OR = 0.93,
p = 0.82
OR = 0.90,
p = 0.74

7.5%
2.0%
12.8%
12.3%
13.3%
10.4%
13.7%
10.0%
16.1%
11.4%
3.80 (1.51)
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Range
2 – 15
M (SD)
6.00 (2.71)
Male
52.6%
0.4%
0
1
--Sex
Female
47.4%
Hispanic/Latinx 57.5%
------Ethnic
Non-Hispanic
Identification
42.5%
White
Note. Analyses were performed on 254 pediatric patients across 4 time points. aTotal values represent
the mean (SD) score/value across all days. b Odds ratios (OR) are from the binary logistic regression
models comparing rates of missing data for Hispanic/Latinx and NHW patients, while controlling for
hospital site.
Age

Table 2.
Average Parent-Reported Pain and Hydrocodone/APAP Consumption for Hispanic/Latinx and
Non-Hispanic White Patients Throughout the Postoperative Week
Hydrocodone/APAP
Parent-Reported Pain
Consumption (mg/kg)
Day 1
n
M (95% CI)
n
M (95% CI)
Hispanic/Latinx
102
5.75 (5.22, 6.29)
88
0.15 (0.11, 0.19)
Non-Hispanic White
94
5.45 (4.98, 5.91)
87
0.25 (0.21, 0.28)
Day 2
Hispanic/Latinx
96
5.29 (4.74, 5.84)
80
0.17 (0.13, 0.22)
Non-Hispanic White
90
5.12 (4.56, 5.68)
78
0.22 (0.18, 0.26)
Day 3
Hispanic/Latinx
80
4.61 (3.97, 5.25)
59
0.19 (0.13, 0.24)
Non-Hispanic White
80
3.78 (3.26, 4.30)
68
0.21 (0.17, 0.25)
Day 7
Hispanic/Latinx
95
3.97 (3.41, 4.53)
64
0.06 (0.02, 0.09)
Non-Hispanic White
74
3.16 (2.59, 3.74)
45
0.08 (0.03, 0.08)
Parent-Reported Pain
Results of Model 1 revealed that 44% of the variance in pain severity could be explained
by between-patient variations (Table 3). Results of Model 2a showed that on average, pain
decreased overtime (p < 0.001), that each patient's initial pain score was different, UN (1,1) =
0.52, and that the linear decrease in pain was different for each patient, UN (2,2) = 0.05. The
quadratic trend (Model 2b) was non-significant (p = 0.07), and was not retained. All fixed effect
predictors were included in Model 3, which was the best fitting model. At the within-patient
level, parents that reported higher levels of postoperative pain were more likely to administer
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both acetaminophen and hydrocodone/APAP to the pediatric patient. At the between-patient
level, ethnicity was significantly associated with pain. In support of Hypothesis 1, parents of
Hispanic/Latinx patients indicated that their children experienced greater pain severity, even
when controlling for differences in medication use.
Hydrocodone/APAP Consumption
Model 1 revealed that that 67% of the variance in in hydrocodone/APAP consumption
could be explained by between-patient variations (Table 4). Hydrocodone/APAP use decreased
significantly throughout the post-surgical week (p < .001; Model 2a). This trend was qualified by
significant random effects of time. Each patients' initial hydrocodone/APAP use was different,
UN (1,1) = 0.60, and patient changes in hydrocodone/APAP consumption overtime covaried
with initial use, UN (2,1) = -0.05. As initial dose increased, the slope of the relationship between
time and use decreased. The quadratic effect (Model 2b) was also was significant (p < .001).
Hydrocodone/APAP consumption did not change from day 1 to day 2, and then slightly
decreased on day 3, with the largest decrease from day 3 to day 4 (Table 1). Model 2b was a
better fitting model (p < .001); thus, both the linear and quadratic components were retained in
the subsequent analyses.
Model 3 was the best fitting model. At the within-patient level, patients who took
additional acetaminophen were less likely to consume hydrocodone/APAP, and those who
experienced greater pain were more likely to consume hydrocodone. At the between-patient
level, findings disclosed no significant main effect of ethnicity (Hypothesis 2); however, an
examination of average hydrocodone/APAP usage (Table 2) did show that Hispanic/Latinx
patients consumed less hydrocodone on each postoperative day. Hypothesis 3 was supported by
the significant interaction of ethnic identification and pain. A test of simple slopes indicated that
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the relationship between parent-reported pain and hydrocodone/APAP consumption was stronger
for NHW patients, b = 0.26, SE = 0.05, p < 0.001, than for Hispanic/Latinx patients, b = 0.12, SE
= 0.04, p = 0.01, suggesting findings that NHW patients were more likely to consume higher
doses of hydrocodone/APAP when parents perceived them as experiencing clinically significant
pain (Figure 2). The region of significance for pain level ranged from -2.75 to 3.12, with values
outside this region statistically significant.
Auxiliary Sensitivity Analysis: Additional Acetaminophen Consumption
A post-hoc sensitivity analysis was conducted to assess whether ethnic identification and
pain severity interacted to also predict acetaminophen use. The relationship between ethnicity
and acetaminophen use was not significant, β = 0.07, (95% CI: -0.05, 0.18, p = 0.27), and the
interaction of ethnicity and pain was also not statistically significant, β = -0.06, (95% CI: -0.13,
0.01), p = .07. Simple slopes analyses showed that the relationship between pain and
acetaminophen use was not significant for NHW, b = 0.01, SE = 0.08, p = 0.90, or
Hispanic/Latinx, b = 0.07, SE = 0.06, p = 0.27, patients.
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Table 3.
Standardized Estimates from the Longitudinal Multilevel Model Predicting Parent-Reported Pain
Model 1
Model 2a
Model 2b
β
p-value
β
p-value
β
p-value
Fixed-Effect Predictors
0.01 (-0.09,
0.07 (-0.14,
Intercept
0.00 (-0.10, 0.10) 0.96
0.88
0.28
0.11)
0.12)
-0.31 (-0.37, -0.32 (-0.37, < 0.001
< 0.001
Time
0.25)
0.26)
-0.06 (-0.12,
Time x Time
0.07
0.00)
Level 1 (within-patient predictors)
Acetaminophen
Hydrocodone
Level 2 (between-patient predictors)
Year
Site: Children’s Hospital of
Orange County
Site: Children’s Hospital of Los
Angeles
Procedure: Adenoidectomy

β

Model 3

p-value

0.12 (0.02, 0.22)

0.02

-0.16 (-0.22, -0.09)

< 0.001
0.002

0.14 (0.05, 0.23)
0.23 (0.13, 0.33)

< 0.001
0.53

-0.04 (-0.15, 0.07)

0.84

-0.02 (-0.17, 0.14)

0.06

-0.13 (-0.26, 0.01)

0.21

-0.07 (-0.18, 0.04)

0.20

Procedure: Tonsillectomy
Family Income
Parent Education

-0.07 (-0.17, 0.04)
0.04 (-0.11, 0.19)
-0.06 (-0.21, 0.09)

0.60
0.44
0.18

Age

-0.07 (-0.17, 0.03)

0.90

Sex

-0.01 (-0.09, 0.11)

0.03

Ethnic Identification

-0.15 (-0.28, -0.01)

0.02

Random Effects (Covariance Parameters)
UN (1,1)
UN (2,1)

β

p-value

β

p-value

β

p-value

β

p-value

0.44
---

.06
---

0.51
0.01

< 0.001
0.74

0.52
0.01

< 0.001
0.66

0.42
0.01

< 0.001
0.79

16
UN (2,2)
----0.05
0.01
0.05
0.01
0.03
0.16
Note. Model 1 intraclass correlation = 0.44. The site reference group was the Children’s Hospital, Colorado. The reference group for sex was
male; the reference group for ethnic identification was Hispanic/Latinx; the reference group for procedure was tonsillectomy & adenoidectomy
surgery. Estimates represent standardized coefficients and (95% CI).

Table 4.
Standardized Estimates from the Longitudinal Multilevel Model Predicting Hydrocodone/APAP Consumption

Fixed-Effect Predictors
Intercept

β

Model 1

p-value

-0.13(-0.24, -0.01) 0.03

Model 2a
β
p-value
-0.14 (-0.25,
-0.03)
-0.19 (-0.25,
-0.13)

0.06 (-0.07,
0.18)
-0.25 (-0.30,
-0.19)
-0.18 (-0.24,
-0.12)

β

Model 3

p-value

0.36

0.09 (0.00, 0.18)

0.06

< 0.001

-0.21 (-0.26, -0.16)

< 0.001

< 0.001

-0.22 (-0.27, -0.16)

< 0.001

Acetaminophen

-0.42 (-0.48, -0.35)

< 0.001

Hydrocodone

0.18 (0.12, 0.24)

< 0.001

Year

0.02 (-0.06, 0.10)

0.66

Site: Children’s Hospital of
Orange County

-0.36 (-0.47, -0.25)

< 0.001

Site: Children’s Hospital of Los
Angeles

-0.17 (-0.27, -0.07)

0.001

Procedure: Adenoidectomy

-0.05 (-0.14, 0.03)

0.24

Time
Time x Time

0.01

Model 2b
β
p-value

< 0.001

Level 1 (within-patient predictors)

Level 2 (between-patient predictors)
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Procedure: Tonsillectomy

0.06 (-0.02, 0.14)

0.15

Family Income

-0.08 (-0.19, 0.03)

0.17

Parent Education

-0.02 (-0.13, 0.09)

0.77

Age

0.05 (-0.03, 0.12)

0.24

Sex

0.01 (-0.06, 0.09)

0.71

Ethnic Identification

-0.01 (-0.11, 0.09)

0.91

Cross-level interaction
Ethnic Identification x Pain

0.07 (0.01, 0.13)

0.02

Random Effects (Covariance Parameters)
β
p-value
β
p-value
β
p-value
β
p-value
UN (1,1)
0.651
< 0.001
0.60
< 0.001 0.59
< 0.001 0.22
< 0.001
UN (2,1)
-----0.06
0.02
-0.06
0.01
-0.01
0.49
UN (2,2)
----0.02
0.26
0.03
0.15
0.01
0.45
Note. Model 1 intraclass correlation = 0.67. The site reference group was the Children’s Hospital, Colorado. The reference group for sex was
male; the reference group for ethnic identification was Hispanic/Latinx; the reference group for procedure was tonsillectomy and
adenoidectomy surgery. Estimates represent standardized coefficients and (95% CI).

18
Discussion
Under the conditions of this study, Hispanic/Latinx parents were shown to perceive their
children as experiencing higher levels of postoperative pain compared to parents of NHW
patients. Despite these higher levels of pain, no differences in at home opioid consumption were
found based on ethnic identification alone. Instead, an interaction was found between ethnicity
and pain, such that Hispanic/Latinx parents were less likely to administer opioids based on
children’s pain severity. In contrast, NHW parents were more likely to administer opioids in
reaction to their children’s pain, dispensing more opioids as children’s pain severity increased.
Explanations for the cultural differences observed in this research are complex; thus, a
biopsychosocial model (66) of pain that considers the interaction of biological, psychological,
and sociocultural processes might be useful for understanding ethnic differences in pain
management observed in this study. At a psychological and sociocultural level, findings should
be interpreted in context of the opioid epidemic. Parent fears about prescription opioids are likely
to act as a barrier to effective pain management (10, 48), making postsurgical pain management
in children a significant concern (10, 11, 67). In other words, parents’ worries about the negative
consequences of opioids may lead them to undertreat their child’s pain. Although about 80% of
children report significant postoperative pain (10, 68, 69), less than 50% of these patients receive
adequate pain relief (14). This is troubling, as inadequately controlled postoperative pain can
negatively impact quality of life, increase risk of complications, and interfere with overall
surgical recovery (16, 17). Despite their side effects, opioids are the mainstay of treatment for
acute postoperative pain and are shown to effectively help with acute pain management (12).
Thus, understanding the misconceptions and barriers linked with opioid pain management among
Hispanic/Latinx patients is important for ensuring optimal pain management at home.
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Past research by our group supports that psychological and social factors can impact
suboptimal pain management at home, including pain assessment, attitudes about analgesic
medications, and cultural bias (10, 15, 48, 70). In prior studies, Hispanic/Latinx parents have
reported greater misconceptions about analgesic use for children including a greater fear of side
effects and addiction (48), and parents with greater misconceptions have been previously shown
to under medicate their children after surgery (69). Parents also tend to endorse inaccurate beliefs
about pain expression. Specifically, a previous study showed that many Hispanic/Latinx parents
believed children always express pain by crying or whining (15), despite research suggesting that
children do not always communicate to their parents when they are in pain (71). In the current
study, Hispanic/Latinx parents realized their child was in pain, but did not adjust opioid or nonopioid acetaminophen dosing accordingly. Thus, in combination with previous research by our
group, findings of the current investigation suggest that Hispanic/Latinx children are at risk for
undertreatment of surgical pain, and highlight the importance of assessing parent background
and cultural beliefs as predictors of at home pain management.
Racial/ethnic inequalities in acute pain management have been documented in other
settings (32-34, 36). Therefore, characteristics of the health delivery system could also act as a
barrier to optimal pain management, since Hispanic/Latinx Americans face disparities in both
access to care and the quality of care received (41). These barriers to care and resulting
disparities are likely to lead to an overall mistrust of healthcare providers recommendations (19).
Parents with fears about opioids and financial limitations on their ability to pay for prescribed
medications might decide to exhaust other options and seek alternative treatments before
subjecting their child to the perceived dangerous effects of opioid medications. Also,
identification with an underrepresented group can be associated with stressful experiences (e.g.,
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discrimination, acculturation, difficulties obtaining health insurance) (41, 72). Stress shown to be
related with cortisol production and continual activation of the hypothalamus-pituitary adrenal
axis, which can impact pain perception and processing (73). In turn, prolonged cortisol
production from psychological distress might contribute to the higher levels of pain perceived by
Hispanic/Latinx parents (74).
Results should be interpreted in light of several limitations. The average age of patients
included in this study was 6 years old (with age ranging from 2 to 15 years old), implying that
findings might not be generalizable to older adolescent samples. Though physicians within the
same hospital prescribe patients of similar age and procedure the same medications post-surgery,
information on each individual prescription was not recorded. Thus, we could not determine
whether Hispanic/Latinx children were prescribed opioids at different rates compared to their
NHW counterparts. The information provided to patients and caregivers are intended to be the
same for all, but this was not dictated or evaluated as part of this study. Future investigations
might examine the relationship between each physician-prescribing pattern, discharge education,
and at home use of pain medication. While some studies suggest that pain scores reported by
parents are highly correlated with child-reported pain levels (75, 76), other investigations have
found that parents overestimate their children's pain severity (70). Therefore, the use of parentreported pain also represents a limitation.
Although parents were instructed to provide real-time assessments of their child's pain
management by indicating the time each dose was administered (14), the parent-reported nature
of opioid use also presents a potential limitation due to the possibility of response bias and
underreporting. In the future, researchers might consider using alternative medication use
measures, such as electronic medication packaging devices (77). Further, an alternative
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explanation to the observed findings could be that NHW parents overmedicated their children,
while Hispanic/Latinx parents administered the correct amount of opioid medications. As such,
additional research is needed to assess the relationship between postoperative opioid
consumption and later misuse.
Conclusion
Findings suggest that parents of Hispanic/Latinx children perceived their children as
experiencing greater pain severity following T&A surgery. Although Hispanic/Latinx patients
did consume less hydrocodone than NHW children on each postoperative day, statistically
significant differences in hydrocodone consumption were not found. Instead, Hispanic/Latinx
children reporting high levels of postsurgical pain were less likely to receive increased doses of
opioids compared with NHW children experiencing similar pain levels. Findings support a
growing body of research that suggests Hispanic/Latinx patients are at risk for experiencing
inadequate pain management at home following ambulatory surgery (14, 15, 48). Accordingly,
future investigations might focus on developing culturally sensitive interventions tailored to
parental demographic characteristics that focus on parental monitoring and management of
children's pain at home (for a review of parent-targeted interventions see 78). Such an
intervention could be tailored based on the user's cultural background and language preference
(79), and might be delivered using online or smartphone modalities (80-82). Efforts could be
tailored to parent literacy and matched based on reported barriers (e.g., fear of overdose or
addiction) and cultural values (e.g., the role of religion and familism).
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Figure 1. Interaction of parent-reported pain level and ethnic identification on hydrocodone/APAP
consumption (mg/kg) from the multilevel model analysis shown in Table 4.
Hispanic/Latinx patients are represented by the solid line; Non-Hispanic White (NHW)
patients are represented by the dashed line. Hydrocodone/APAP consumption ranged from
0.00 to 0.82. However, the scale of hydrocodone/APAP consumption (y-axis) displayed in
this figure was truncated to maintain conceptual clarity. Error bars represent 95%
confidence intervals.

